Abstract
Objective: To evaluate the association of the degree of gingival inflammation and 25-hydroxy Vitamin D (25(OH)D) level in postmenopausal women.Methods: A cross-sectional study involved 71 postmenopausal women. Data were obtained using questionnaires, clinical periodontal examinations, and evaluations of blood samples. Serum 25(OH)D concentrations were determined using human 25-dihydroxy Vitamin D ELISA kit.Result: Prevalence of Vitamin D deficiency among postmenopausal women was 74.64%. The papillary bleeding index (PBI) was lower (1.07±0.18) in postmenopausal women with normal serum 25(OH)D levels than that in postmenopausal women with Vitamin D deficiency (1.41±0.1). However, this difference was not statistically significant (p<0.05). This result indicated increasing trends in PBI.Conclusion: There is no association between the degree of gingival inflammation and the 25(OH)D status among postmenopausal women.
Highlights
Menopause is defined as the cessation of menstruation for at least 1 year due to estrogen deficiency
There is no association between the degree of gingival inflammation and the 25(OH)D status among postmenopausal women
This study showed that the women with normal 25(OH)D levels (16.06 ± 3.95 min/week) tended to have longer sun exposure than those with Vitamin D deficiency (15.33 ± 2.97 min/week); this difference was not statistically significant (Table 3)
Summary
Menopause is defined as the cessation of menstruation for at least 1 year due to estrogen deficiency. A considerable proportion of the population is affected by estrogen deficiency; there are approximately 70 million women in the United States >50 years of age [1]. It is estimated that there will be 60 million menopausal women in Indonesia by 2025. In Indonesia, there are 14 million menopausal women, comprising 7.4% of the total population [2]. Multiple health issues affect postmenopausal women and compromise their quality of life. Postmenopausal women may experience several symptoms [3], including cardiovascular disease, osteoporosis, cancer, cognitive decline and dementia, chronic obstructive pulmonary disease, diabetes mellitus, metabolic syndrome, depression, vasomotor symptoms, sleep disturbances, and migraine [3,4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.